National Bank of Canada’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1K | Hold |
513
| – | – | ﹤0.01% | 1658 |
|
|
2025
Q1 | $46.7K | Buy |
513
+72
| +16% | +$6.56K | ﹤0.01% | 1593 |
|
|
2024
Q4 | $38K | Sell |
441
-13,235
| -97% | -$1.14M | ﹤0.01% | 1668 |
|
|
2024
Q3 | $1.3M | Sell |
13,676
-100
| -0.7% | -$9.5K | ﹤0.01% | 923 |
|
|
2024
Q2 | $1.26M | Sell |
13,776
-220
| -2% | -$20.1K | ﹤0.01% | 903 |
|
|
2024
Q1 | $1.25M | Buy |
13,996
+353
| +3% | +$31.5K | ﹤0.01% | 943 |
|
|
2023
Q4 | $1.13M | Sell |
13,643
-1,779
| -12% | -$147K | ﹤0.01% | 983 |
|
|
2023
Q3 | $1.21M | Sell |
15,422
-209
| -1% | -$16.4K | ﹤0.01% | 971 |
|
|
2023
Q2 | $1.23M | Sell |
15,631
-672
| -4% | -$52.9K | ﹤0.01% | 973 |
|
|
2023
Q1 | $1.27M | Sell |
16,303
-1,025
| -6% | -$79.6K | ﹤0.01% | 882 |
|
|
2022
Q4 | $1.35M | Sell |
17,328
-2,533
| -13% | -$197K | ﹤0.01% | 896 |
|
|
2022
Q3 | $1.33M | Sell |
19,861
-484
| -2% | -$32.3K | 0.01% | 775 |
|
|
2022
Q2 | $1.56M | Buy |
20,345
+16,205
| +391% | +$1.24M | 0.01% | 724 |
|
|
2022
Q1 | $330K | Sell |
4,140
-300
| -7% | -$23.9K | ﹤0.01% | 1182 |
|
|
2021
Q4 | $342K | Buy |
+4,440
| New | +$342K | ﹤0.01% | 1165 |
|